Dr. Atweh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1201 Camino de Salud NE
Albuquerque, NM 87102Phone+1 505-272-4946Fax+1 505-272-8060
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1980 - 1983
- American University of Beirut Faculty of MedicineClass of 1978
Certifications & Licensure
- NM State Medical License 2017 - 2027
- VT State Medical License 2014 - 2018
- FL State Medical License 2014 - 2016
- OH State Medical License 2009 - 2015
- NY State Medical License 1990 - 2009
- MI State Medical License 1985 - 1992
- CT State Medical License 1983 - 1985
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2001
- Top MD Consumers Checkbook
Clinical Trials
- Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers Start of enrollment: 1997 Sep 01
Publications & Presentations
PubMed
- 305 citationsThe role of stathmin in the regulation of the cell cycleCamelia Iancu Rubin, George F. Atweh
Journal of Cellular Biochemistry. 2004-10-01 - 58 citationsInduction of Fetal Hemoglobin in the Treatment of Sickle Cell DiseaseHassana Fathallah, George F. Atweh
Hematology. American Society of Hematology. Education Program. 2006-01-01 - 68 citationsButyrate increases the efficiency of translation of γ-globin mRNARona Singer Weinberg, Xinjun Ji, Millicent Sutton, Susan P. Perrine, Yelena Galperin
Blood. 2005-02-15
Grant Support
- Pulse Arginine Butyrate With Standard Hydroxyurea Therapy In Sickle CellNational Center For Research Resources2006–2007
- Reversal Of Epigenetic Silencing Of The G-Globin GeneNational Heart, Lung, And Blood Institute2003–2006
- Induction Of Fetal Hemoglobin With Arginine ButyrateNational Heart, Lung, And Blood Institute1998–2002
- In Vitro Models Of Sickle Cell Gene TherapyNational Heart, Lung, And Blood Institute1998–2002
- Clinical Trial Of IV Butyrate In Fetal Hemoglobin Beta Globin DisordersNational Center For Research Resources1998–2002
- Retroviral Mediated Globin Gene TherapyNational Heart, Lung, And Blood Institute1997–2000
- Study Of Oral Isobutyramide Increasing Fetal Hemoglobin In Beta Globin DisordersNational Center For Research Resources1997
- Study Of Clinical And Molecular Correlations In The S/Beta ThalassemiaNational Center For Research Resources1997
- Clinical Trial Of IV Butyrate--Fetal Hemoglobin Beta Globin DisordersNational Center For Research Resources1996–1997
- Retroviral Mediated Globin Gene TherapyNational Heart, Lung, And Blood Institute1996
- Pharmacologic/Gene Therapy Approaches To Treatment Of Hemoglobin DisordersNational Center For Research Resources1995
- Normal And Aberrant Globin Gene ExpressionNational Heart, Lung, And Blood Institute1994–1995
- Study Of Normal And Aberrant Globin Gene ExpressionNational Heart, Lung, And Blood Institute1992–1993
- Normal And Aberrant Globin Gene ExpressionNational Heart, Lung, And Blood Institute1989–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: